BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,741 | -99.9% | 85,400 | +24.9% | 0.01% | 0.0% |
| Q1 2022 | $4,369,000 | -67.4% | 68,400 | -55.1% | 0.01% | -70.6% |
| Q2 2021 | $13,403,000 | -30.9% | 152,374 | -23.6% | 0.02% | -29.2% |
| Q1 2021 | $19,388,000 | -38.7% | 199,400 | -29.3% | 0.02% | -29.4% |
| Q4 2020 | $31,615,000 | +84.2% | 281,900 | +52.2% | 0.03% | +100.0% |
| Q3 2020 | $17,168,000 | +268.6% | 185,200 | +210.2% | 0.02% | +325.0% |
| Q2 2020 | $4,657,000 | -27.1% | 59,700 | -45.3% | 0.00% | -33.3% |
| Q1 2020 | $6,386,000 | -59.1% | 109,200 | -55.6% | 0.01% | -33.3% |
| Q2 2018 | $15,603,000 | +2267.7% | 245,800 | +1790.8% | 0.01% | +800.0% |
| Q2 2017 | $659,000 | -55.9% | 13,000 | -65.2% | 0.00% | -50.0% |
| Q1 2017 | $1,496,000 | +407.1% | 37,400 | +256.2% | 0.00% | – |
| Q4 2016 | $295,000 | -11.4% | 10,500 | -6.2% | 0.00% | -100.0% |
| Q3 2016 | $333,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |